A study has newly identified an immune trigger of some fibrotic diseases and an experimental compound to treat it. Fibrosis — a progressive scarring and hardening of internal organs — is estimated to cause 35 to 40 percent of deaths in the world.
A study has newly identified an immune trigger of some fibrotic diseases and an experimental compound to treat it. Fibrosis — a progressive scarring and hardening of internal organs — is estimated to cause 35 to 40 percent of deaths in the world.